Medical conclave urges stronger push for gender-neutral HPV vaccine for boys
Pune: Boys, along with girls, must be vaccinated against Human Papillomavirus (HPV), doctors at the launch of the "Conquer HPV & Cancer Conclave 2025" last week said.
Panelists said that govt backs vaccination for girls under the Universal Immunization Programme (UIP), but boys and men, who are carriers of the virus, are equally affected by HPV and cancer-causing HPV and hence must also be vaccinated.
Speakers emphasised that HPV is not limited to cervical cancer alone. It is also associated with cancers of the sexual organs, affecting both men and women. With peak HPV infection occurring between ages 15 to 25, early awareness and timely preventive action are essential.
Medical director of Bharati Vidyapeeth Medical College & Hospital Dr Sanjay Lalwani, who anchored the panel discussion, said the indigenous vaccine, Cervavac, is effective, safe and affordable.
He added, "It is a gender-neutral vaccine and boys must also get vaccinated. While women can be screened regularly through a pap smear test, as of now men do not have any screening programme. So, boys between the age of 9 and 14 years must also be vaccinated, just like girls."
Vaccination can protect partners from HPV-related cancers in adult life. There is no specific way to test directly for HPV in men that is approved for clinical use.
The American Sexual Health Association has observed that men are typically screened clinically with a visual inspection to check for lesions such as warts.
While still not routinely done, anyone with a history of receptive anal sex may want to speak with his or her healthcare provider about having an anal pap test, the association said.
Dr Meenu Agarwal, secretary-general of International Society of Gynaecological Endoscopy, said, she sees young girls and women with genital warts and cervical cancer cases.
"Now, when we go to the root of the problem, we realize that it is a sexually transmitted disease and that is the reason we need to vaccinate both boys and girls because we need to take care of the source of the spread."
The rationale is to prevent different types of cancers that can occur in men as well, Dr Shirish Kankariya, former president of Indian Academy of Paediatrics, said.
Parag Deshmukh, executive director, Serum Institute of India said, "Conclaves across the country will help increase understanding of Human Papillomavirus (HPV) and its link to cervical and other cancers."
The conclave is part of a nationwide public health initiative led by the institute.
77k Cervical Cancer Deaths
India bears a significant burden of HPV-related diseases, particularly cervical cancer, the second most common cancer among women in the country
According to the ICO/IARC Information Centre on HPV and Cancer (2023), India reports over 1.23 lakh new cervical cancer cases and more than 77,000 related deaths, annually
Up to 90% of anal cancers & 63% of penile cancers are associated with HPV
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Hindustan Times
2 hours ago
- Hindustan Times
A mission for a tech-forward future
In India, when we think of flagship missions in science and technology, names like the Indian Space Research Organisation (Isro) or Digital India come to mind. But over the past six years, another equally ambitious initiative has been quietly laying the foundation for India's future in deep-tech innovation. The National Mission on Interdisciplinary Cyber-Physical Systems (NM-ICPS), launched by the department of science and technology in 2018, has emerged as one of the most transformative efforts in building the nation's cyber-physical infrastructure and capabilities. In a world where technology is the new geopolitical currency, India cannot afford to be a mere consumer. (Getty Images/iStockphoto) This progress has been possible due to the progressive policies and sustained support of Prime Minister Narendra Modi's government over the past 11 years, especially in fostering research, innovation, and deep-tech entrepreneurship in the country. NM-ICPS is not a typical government programme. It did not stop at policy or paperwork. It has built a working ecosystem from scratch. At the heart of NM-ICPS are 25 Technology Innovation Hubs located in some of the country's top academic and R&D institutions. Each of these hubs is focused on a frontier technology area — artificial intelligence, robotics, IoT, quantum tech, cybersecurity, autonomous systems, blockchain, and more. But what sets them apart is not just their focus. It is the integration of research, entrepreneurship, product development, and skills training that makes this mission both unique and scalable. Over 1700 technology products and solutions have been developed under this mission so far. These are not just prototypes sitting on lab shelves. Many are being actively deployed in sectors like healthcare, agriculture, energy, defence, and logistics. Several are aligned with India's national priorities such as food security, public safety, and inclusive digital access. Importantly, these are homegrown technologies—designed in India, for India. Innovation alone, however, is not enough unless it reaches people and markets. That is where the NM-ICPS architecture has shown foresight. More than 900 startups have been supported by the hubs, across domains like drone tech, quantum communication, digital forensics, speech analytics and AI/ML-based diagnostics. These are deep-tech ventures, often started by young graduates and researchers, which would have struggled to find the right support in a conventional system. The mission has also facilitated over 150 international collaborations, opening up new avenues for cross-border technology partnerships. Skill development has been another major pillar. Over 1.6 lakh individuals have been trained through TIH-led programmes in CPS-related domains. These include students, researchers, industry professionals, and even school teachers in some cases. Building a future-ready workforce is essential if India is to stay competitive in these technologies. One of the most significant initiatives last year was the launch of BharatGen, a multilingual, multimodal large language model initiative being developed at IIT Bombay. Unlike generic models that lack context or cultural sensitivity, BharatGen aims to develop foundational AI models grounded in Indian languages, social nuances, and local data ecosystems. This could become a game-changer for inclusive digital public infrastructure and India's AI ambitions. The mission also underwent an independent Third-Party Evaluation recently. Most government schemes shy away from such scrutiny. But NM-ICPS welcomed it. The evaluation team not only affirmed the impact and relevance of the mission but also recommended enhancements in institutional frameworks for faster translation and scale. The assessment also led to the selection of four Technology Innovation Hubs for upgradation into full-fledged Technology Translation Research Parks (TTRPs). These TTRPs — at IIT Indore (digital health), IISc Bangalore (robotics & AI), IIT Kanpur (cybersecurity), and IIT Dhanbad (mining tech) — will serve as national anchors for turning lab innovations into scalable commercial solutions. The selection was based on rigorous performance benchmarks, including translational outcomes, industry linkages, and revenue generation, and the upgradation will empower them with enhanced funding and infrastructure to lead national-level deep-tech innovation efforts. This is a significant leap. India has often struggled to move from lab to market, particularly in hardware-centric and deep-tech areas. These new TTRPs will bridge that gap by integrating research, validation, piloting, standards, and industry partnerships under one roof. Too often, we compare ourselves with Silicon Valley or Tel Aviv and lament the lack of deep-tech innovation in India. But missions such as NM-ICPS show that when the vision is right, when institutions are trusted and when academia is empowered, we can build ecosystems that deliver not just research papers but real impact. This journey is still evolving. More needs to be done to sustain and expand the gains. We need stronger linkages with user ministries, better market access for start-ups, more industry co-investment, and a policy environment that encourages risk-taking. But the foundation has been laid. The institutional architecture is working. The innovations are real. The startups are scaling. And the talent pipeline is growing. In a world where technology is the new geopolitical currency, India cannot afford to be a mere consumer. We need to shape the rules, build the tools, and train the minds that will define this century's technological landscape. The NM-ICPS mission is a bold step in that direction. It deserves greater visibility, deeper support, and sustained momentum. Because in the end, it is not just about creating technology. It is about creating national capacity, confidence, and conviction in our own potential. V Ramgopal Rao is vice-chancellor, BITS Pilani group of institutions, and former director, IIT Delhi. He chairs the Scientific Advisory Committee of NM-ICPS. The views expressed are personal.
Time of India
6 hours ago
- Time of India
Heart care in golden hour: New initiative aims to reduce STEMI deaths
Lucknow: To improve emergency heart care in semi-urban and rural areas, the state govt has launched the UP STEMI Care Program in SGPGIMS . This initiative uses tele-ECG technology to detect heart attack s in remote regions within minutes and aims to reduce deaths from ST-Elevation Myocardial Infarction (STEMI) - one of the deadliest and most time-sensitive forms of heart attack. The initiative follows a spoke-and-hub model. District hospitals and CHCs in Rae Bareli, Sultanpur and Amethi (spokes) will begin clot-busting treatment within the golden hour, the critical first hour after a heart attack. Patients will then be referred to advanced centres like SGPGIMS (hubs) for angioplasty (PCI) within 3-24 hours. This ensures timely, evidence-based heart attack care, even in low-resource settings. The initiative also enables real-time ECG transmission from local health facilities to expert centres like SGPGIMS, allowing trained cardiologists to interpret ECGs remotely and guide treatment decisions. Prof Aditya Kapoor, head of the cardiology department at SGPGIMS, said, "It's a leap forward in reducing preventable cardiac deaths in UP... Heart diseases are the leading cause of death, accounting for over 28% of all fatalities. Indians develop heart blockages almost 10 years earlier than people in western countries. Nearly 50% of first heart attacks occur before the age of 55, and 25% even before 40. In UP alone, about five lakh people suffer from STEMI each year." "Among people aged 40-69 and those above 70, heart blockages cause nearly 25% of all deaths. Even among those below 40, it accounts for about 10% of fatalities. Disability related to heart blockages has increased 1.5 to 2 times over the past 30 years," he said. Prof Kapoor said, "We also plan to incorporate AI-based applications to speed up ECG analysis. While a standard 12-lead ECG takes 5 to 10 minutes to generate and interpret, AI-enabled ECGs using just a single lead can accurately predict the possibility of a heart attack." Dr Ankit Sahu, additional professor, cardiology, said that lack of awareness, poor transport and limited ECG facilities at peripheral health centres often delay the diagnosis. Partha Sarthi Sen Sharma, principal secretary, medical health, said, "The programme represents a robust doctor-govt partnership that prioritises equitable access to life-saving care. With this rollout, UP aims to reduce STEMI-related mortality and serve as a blueprint for scalable cardiac care delivery across India." SGPGIMS director Prof R K Dhiman assured full support from SGPGIMS in implementing and expanding the initiative across the state.
The Print
9 hours ago
- The Print
Decline in percentage of zero-dose children due to govt's proactive, inclusive approach: Health Ministry
The ministry credited the decline in such children to its unwavering commitment to immunisation evident through its Universal Immunization Programme (UIP), which provides free vaccination services annually to 2.9 crore pregnant women and 2.6 crore infants (0′-1 year). According to WHO, zero-dose children are defined as those who lack access to or are never reached by routine immunisation services. They are operationally measured as those who did not receive their first dose of DTP (diphtheria-tetanus-pertussis). New Delhi, Jun 28 (PTI) India's percentage of zero-dose children to the total population has declined from 0.11 per cent in 2023 to 0.06 per cent in 2024, positioning it as a global exemplar in child health, as acknowledged by the UN Inter-agency Group for Child Mortality Estimation in its 2024 report, the Union Health Ministry said here. At the same time, it asserted that any comparison of India with any other countries with high burden zero dose children needs to take into consideration India's large population size and high vaccination coverage rate. Vaccination remains one of the most powerful and cost-effective public health interventions, the ministry said in a statement, noting that the government has taken a proactive and inclusive approach to reach underserved populations. 'Our healthcare workers ASHAs and ANMs conduct over 1.3 crore immunisation sessions across the country,' the statement said. 'As a result of the continued, sustained efforts and intensified implementation of vaccination drives and campaign across the country, the percentage of zero-dose children to the total population has declined from 0.11 per cent in 2023 to 0.06 per cent in 2024,' it said The approach remains progressive, and continuous efforts are being made in the current year to further reduce the burden of zero-dose children in the country, it said. These achievements have positioned India as a global exemplar in child health, as acknowledged by the UN Inter-agency Group for Child Mortality Estimation (UN IGME) in its 2024 report, it said. The effect of the increased number of lifesaving vaccines in reducing mortality and morbidity in children due to diarrhoea, pneumonia, meningitis and encephalitis is also clearly observable, the statement said. According to the latest SRS (2020-22), the Maternal Mortality Ratio (MMR) in India has declined from 130/lakh live births in 2014-16 to 88/lakh live births in 2020-22. The United Nations Maternal Mortality Estimation Inter-Agency Group (UN-MMEIG 2000-2023) report says that the MMR in India stands at 80 per lakh live births, reflecting an 86 per cent decline relative to the global reduction of 48 per cent since 1990, it stated. According to the United Nations Inter-Agency Group for Child Mortality Estimation (UNIGME 2024 Report), India achieved a 78 per cent decline in the Under-Five Mortality Rate (U5MR) surpassing the global reduction of 61 per cent and 70 per cent decline in the Neonatal Mortality Rate (NMR) compared to 54 per cent globally during 1990 – 2023. In addition to focused attention on increasing vaccination coverage, India's UIP embodies a comprehensive range of vaccines recommended by the World Health Organization (WHO). Till 2013, there were only six available vaccines in the programme. Currently, India's UIP covers 12 vaccine-preventable diseases and has seen significant expansion, the statement said. With continued focus on improving vaccine coverage, India has taken a proactive and inclusive approach to reach underserved populations. The Government of India in consultation with all states and UTs, has launched targeted campaigns to address challenges among zero-dose children, particularly in urban slums, peri-urban areas, migratory populations, hard-to-reach regions, and communities affected by vaccine hesitancy. 'To amplify our reach, we are leveraging technology and community engagement. The U-WIN platform tracks immunisation status digitally, ensuring no child is missed. 'Public awareness campaigns are being intensified using mass media, community radio, social media, and even street plays to educate families. Healthcare workers, ASHAs, and ANMs will go door-to-door, not just to vaccinate, but to sensitize the beneficiaries about the benefits of vaccination,' the statement said. Some key initiatives include roll out of Zero Dose Implementation Plan 2024 across 143 districts in 11 states with a high burden of unvaccinated children; Mission Indradhanush (since 2014), intensified in 2017 in collaboration with state governments, it has vaccinated 5.46 crore children and 1.32 crore pregnant women — previously unreached or under-vaccinated. The initiatives also include Pulse Polio Campaigns, and Village Health and Nutrition Days (VHNDs) organised regularly for immunisation and outreach activities at the community level. The annual birth cohort in India (2.6 crore) exceeds the total population of several countries, including New Zealand, Australia, Finland, and Switzerland. Given the varying sizes of the countries across the globe, the percentage comparison shows it at par with the vaccination coverage levels observed in many high-income countries for e.g., New Zealand (DTP-1 93%), Germany & Finland (DPT-3 91%), Sweden (MCV-1 93%), Luxembourg (MCV-2 90%), Ireland (PCV-3 83%), United Kingdom of Great Britain and Northern Ireland (Rota C 90%). (WUNEIC report 2023), the statement said. The comparative results of countries on zero dose children as a percentage of the total population shows that Yemen (1.68%), Sudan (1.45%), Angola (1.1%), Afghanistan (1.1%), Nigeria (0.98%), DR Congo (0.82%), Ethiopia (0.72%), Indonesia (0.23%), Pakistan (0.16%) have far more zero dose children as a percentage of their population compared to India's (0.11% during 2023 as per the last Wuneic report released. Any comparison of India with any other countries with high burden zero dose children needs to take into consideration India's large population size and high vaccination coverage rate, the statement said. Therefore, any interpretation or analysis based on isolated factors does not lend credence to the country's progress on its immunization program, it emphasised. PTI PLB RT RT RT RT This report is auto-generated from PTI news service. ThePrint holds no responsibility for its content.
